Related Experiment Videos
The alpha2B adrenergic receptor deletion/insertion polymorphism in morbid obesity
Gerasimos P Sykiotis1, Eftihia Polyzogopoulou, Neoklis A Georgopoulos
1Department of Pharmacology, School of Medicine, University of Patras, 26110 Patras, Greece.
Summary
This study found no significant link between the alpha(2B) adrenergic receptor polymorphism and basal metabolic rate or metabolic syndrome in morbidly obese patients. The genetic variation did not influence key metabolic or cardiovascular markers in this group.
Area of Science:
- Genetics
- Metabolism
- Obesity Research
Background:
- The sympathetic nervous system regulates basal metabolic rate (BMR) and is implicated in metabolic syndrome.
- A specific alpha(2B) adrenergic receptor polymorphism has been previously associated with lower BMR and weight gain predisposition in obese individuals.
- Understanding genetic factors influencing BMR and metabolic syndrome is crucial for obesity management.
Purpose of the Study:
- To investigate the association between the alpha(2B) adrenergic receptor polymorphism and BMR in morbidly obese patients.
- To examine the relationship of this polymorphism with various metabolic syndrome-related parameters in the same patient cohort.
- To determine the functional significance of the alpha(2B) adrenergic receptor polymorphism in morbid obesity.
Main Methods:
- Genotyping of the alpha(2B) adrenergic receptor deletion/insertion polymorphism in morbidly obese patients and a control group.
- Measurement and statistical adjustment of basal metabolic rate (BMR) based on fat-free mass, fat mass, sex, and age.
- Assessment of metabolic syndrome components including BMI, blood pressure, heart rate, lipid profiles, fasting glucose, and uric acid levels.
Main Results:
- Genotype frequencies of the alpha(2B) polymorphism were comparable between morbidly obese patients and controls.
- No significant differences in adjusted BMR were observed among different alpha(2B) genotypes in the patient group.
- The alpha(2B) polymorphism showed no association with BMI, blood pressure, heart rate, cholesterol levels, triglycerides, glucose, or uric acid.
Conclusions:
- The alpha(2B) adrenergic receptor polymorphism does not appear to play a major role in regulating BMR or metabolic syndrome parameters in this cohort of morbidly obese subjects.
- These findings suggest that other genetic or environmental factors may be more influential in the pathophysiology of obesity and metabolic syndrome in this population.
- Further research may be needed to explore alternative genetic markers or pathways involved in metabolic regulation in severe obesity.